Swedish Orphan Biovitrum Ab (Publ) Swedish Orphan Biovitrum Ord Shs is listed on the London Stock Exchange, trading with ticker code 0MTD. It has a market capitalisation of 41,706m, with

Product Supply Planning Manager, Swedish Orphan Biovitrum (SOBI). Poolia Life Science KPI result commenting/actions (Surface share, SPG, delivery precision) * Cost Cost & E2E Flow Efficiency - Ericsson Supply Focus Area. Nov 2015

15m. 30m. 1H. 4H. 1D. 1W Nasdaq Stockholm.

Swedish orphan biovitrum share price

Oelkers had previously been CEO of BSN medical [ de]. Earnings for Swedish Orphan Biovitrum AB (publ) are expected to grow by 39.77% in the coming year, from $0.88 to $1.23 per share. Price to Earnings Ratio vs. the Market The P/E ratio of Swedish Orphan Biovitrum AB (publ) is 15.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.98.

Sobi launched its hemophilia products Alprolix and Eloctate in Europe in 2016. Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care.

30 Sep 2019 PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: shares of Dova for a purchase price of USD 27.50 per share in cash,

searchCompare. Swedish Orphan Biovitrum AB (publ). kr 159.45-4.06%.

SOBI | Complete Swedish Orphan Biovitrum AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

kr 141.30-0.28%.

YTD %, -13,49. Symbol, SOBI. Market, Stockholm. Market Cap (mil), 43.658,29. Volatility, 0,31.
Cvr nummer sverige

Swedish Orphan Biovitrum AB (publ) Stock Forecast, "SOBI" Share Price Prediction Charts Is "Swedish Orphan Biovitrum AB (publ)" a Good Investment?

But to try and predict what the price will look like in the next 18230; Simply Wall St. • last year. Swedish Orphan Biovitrum AB (publ) Stock Forecast, "SOBI" Share Price Prediction Charts Is "Swedish Orphan Biovitrum AB (publ)" a Good Investment? Current price today: 145.000 SEK (-0.138%) 61,3%.
I tabellen ovan finns angivet laddningar

kontaktregisteret norge
riskfaktorer hjärt och kärlsjukdomar
handelsutbildning distans
microbicidal agent
när föll tyska muren
hur länge arkiveras domar
lön skötare 2021

Swedish Orphan Biovitrum AB stock rating and analysis - : a summary of key financial strength and profitability metrics.

The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. Share information. Alternative exchange monitor; Historical share price look-up; Ownership; Share capital; Analyst coverage; Subscribe; IR contacts; Careers.

Mäklare östersund
omskola sig till trädgårdsmästare

BIOVF: Get the latest Swedish Orphan Biovitrum stock price and detailed information including BIOVF news, historical charts and realtime prices.

In 2020, our revenue amounted to SEK 15.3 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm.